Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAAO vs NOAC in AF Patients with PCI
NCT05353140Recruiting
- Sponsor
- Xijing Hospital
- Start
- Sep 2022
- Primary completion
- Sep 2028
- Countries
- 1
01
Overview
Randomised, open-label trial in Atrial fibrillation (AFib) (2 arms), sponsored by Xijing Hospital. Primary endpoint: Major adverse cardiac and cerebrovascular events at 12 months. Started Sep 2022; status: recruiting.
02
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT05353140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05353140.